Goldman Sachs Group Inc Boston Scientific Corp Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 13,929,832 shares of BSX stock, worth $1.43 Billion. This represents 0.24% of its overall portfolio holdings.
Number of Shares
13,929,832
Previous 14,143,332
1.51%
Holding current value
$1.43 Billion
Previous $1.43 Billion
1.51%
% of portfolio
0.24%
Previous 0.24%
Shares
22 transactions
Others Institutions Holding BSX
# of Institutions
1,831Shares Held
1.21BCall Options Held
9.66MPut Options Held
6.98M-
Vanguard Group Inc Valley Forge, PA135MShares$13.8 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$13 Billion0.22% of portfolio
-
State Street Corp Boston, MA64.5MShares$6.63 Billion0.28% of portfolio
-
Primecap Management CO Pasadena, CA36.5MShares$3.75 Billion3.11% of portfolio
-
Wellington Management Group LLP Boston, MA33.2MShares$3.41 Billion0.67% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $147B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...